The potential effect of pre-exposure prophylaxis (PrEP) roll-out on sexual-risk behaviour among adolescents and young people in East and southern Africa.

HIV prevention behaviour change pre-exposure prophylaxis qualitative research methods sexual behaviour sub-Saharan Africa

Journal

African journal of AIDS research : AJAR
ISSN: 1727-9445
Titre abrégé: Afr J AIDS Res
Pays: South Africa
ID NLM: 101146510

Informations de publication

Date de publication:
Mar 2022
Historique:
entrez: 1 4 2022
pubmed: 2 4 2022
medline: 5 4 2022
Statut: ppublish

Résumé

Pre-exposure prophylaxis (PrEP) is an HIV-prevention strategy recommended for those at high-risk of infection, including adolescents and young people (AYP). We explored how PrEP roll-out could influence sexual risk behaviour among AYP in East and southern Africa. Twenty-four group discussions and 60 in-depth interviews were conducted with AYP between 13 and 24 years old, recruited from community settings in Uganda, Zimbabwe and South Africa, from September 2018 to January 2019. Participants perceived that PrEP availability could change sexual behaviour among AYP, influencing: (1) condom use (increased preference for condomless sex, reduced need and decrease in use of condoms, relief from condom use discomfort, consistent condom use to curb sexually transmitted infections and pregnancies); (2) sexual activities (increase in sexual partners and sexual encounters, early sexual debut, sexual experimentation and peace of mind during risky sex, sexual violence and perversion); (3) HIV risk perception (neglect of other HIV prevention strategies, unknown sexual partner HIV status, adoption of PrEP). PrEP initiation may be associated with increased interest in sexual activities and risky sexual behaviour among AYP. PrEP should be included as part of a combination package of HIV prevention strategies for AYP with methods to prevent other sexually transmitted infections and unwanted pregnancies.

Identifiants

pubmed: 35361057
doi: 10.2989/16085906.2022.2032218
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-7

Subventions

Organisme : Medical Research Council
ID : MC_UU_00027/4
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom

Auteurs

Andrew Sentoogo Ssemata (AS)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine, Uganda Research Unit, Entebbe, Uganda.

Richard Muhumuza (R)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine, Uganda Research Unit, Entebbe, Uganda.

Lynda Stranix-Chibanda (L)

University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.

Teacler Nematadzira (T)

University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.

Nadia Ahmed (N)

Desmond Tutu HIV Centre, Faculty of Health Sciences, University of Cape Town, South Africa.
Mortimer Market Centre, Central North West London NHS Trust, London, United Kingdom.

Stefanie Hornschuh (S)

Perinatal HIV Research Unit (PHRU), School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Janan Janine Dietrich (JJ)

Perinatal HIV Research Unit (PHRU), School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Gugulethu Tshabalala (G)

Perinatal HIV Research Unit (PHRU), School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Millicent Atujuna (M)

Desmond Tutu HIV Centre, Faculty of Health Sciences, University of Cape Town, South Africa.

Denis Ndekezi (D)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine, Uganda Research Unit, Entebbe, Uganda.

Phiona Nalubega (P)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine, Uganda Research Unit, Entebbe, Uganda.

Esther Awino (E)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine, Uganda Research Unit, Entebbe, Uganda.

Helen A Weiss (HA)

MRC International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Julie Fox (J)

King's College London, United Kingdom.

Janet Seeley (J)

Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine, Uganda Research Unit, Entebbe, Uganda.
Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH